Status:
UNKNOWN
Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2
Lead Sponsor:
Aalborg University Hospital
Conditions:
HIV Infections
Hepatitis A
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The response to vaccination for hepatitis is reduced in patients with HIV infection. The hypothesis of the study is that adjuvant interleukin-2 administered subcutaneously at the time of vaccination i...
Eligibility Criteria
Inclusion
- Adults with stable antiretroviral therapy and negative for hepatitis A or B
Exclusion
- Prior hepatitis A or B
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00451984
Start Date
March 1 2007
Last Update
November 1 2007
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Infectious Diseases, Aalborg Hospital
Aalborg, Denmark, DK9000
2
Department of Infectious Diseases, Skejby Hospital
Aarhus, Denmark, DK8200